Imagine directing the liver to become a factory to crank out personalized immunotherapies for most cancers and prevent them from spreading. Vironexis came out of stealth today with FDA clearance to begin the first-ever clinical trial of an AAV-delivered cancer immunotherapy. By… https://t.co/vQmstrkF6v https://t.co/xiG0MjYzVU
— Steve Jurvetson (@FutureJurvetson) Sep 12, 2024
from Twitter https://twitter.com/FutureJurvetson
September 12, 2024 at 06:53PM
via IFTTT
No comments:
Post a Comment